AMERSA

AMERSA

Call Us: (401) 615-4047 | Contact Us AMERSA on Twitter AMERSA on LinkedIn AMERSA on BlueSky

Make a Donation Pay a Past-Due Balance Join Our Mailing List
  • About
    • What is AMERSA
    • Board of Directors
    • Donate to AMERSA
    • Contact Us
  • Membership
    • Get to Know AMERSA
    • Join / Renew
    • Who We Are
    • Member Center
    • Special Interest Groups
    • Career Opportunities
    • Professional & Academic Advancement Opps
  • Conference
    • Annual Conference
    • Conference Sponsorship
    • Conference Exhibitor Information
    • Policy and Procedures for AMERSA Events
    • 2024 Conference Materials
    • Past Conference Resources
  • Journal
    • Journal Home
    • About Us
    • Member Access to Journal
    • Author Instructions and Submission
    • SAj Blog
    • SAj Annual Awards
    • SAj Editorial Scholar Program
  • Advocacy
    • AMERSA Advocacy
    • Position Statements
    • Submit a Position Statement
    • Letters of Support
    • Public Comments
  • Sustainability
    • Initiatives
    • Resources
  • Education
    • AMERSA Podcast Series
    • AMERSA Webinars
    • Core Competencies – AMERSA in the 21st Century
    • Resources
  • Awards
    • AMERSA Awards
    • Current Award Winners
    • Past Award Winners

More Effective Communication During Inpatient Addiction Treatment

Jun 2, 2023 by agalloway

The article, “More Effective Communication During Inpatient Addiction Treatment” has been
published in SAj in Volume 44 Issue 1-2.

In this commentary, the authors argue that historical approaches to inpatient addiction treatment favoring more confrontational, expert-centric, or paternalistic undercurrents continue to permeate the hidden curriculum in medical training. These older approaches unfortunately continue to inform how many trainees learn to approach inpatient addiction treatment. The authors go on to provide several examples of how clinical challenges specific to inpatient addiction treatment can be addressed by employing principles of motivational interviewing, harm reduction, and psychodynamic thought.

In the AUTHORS’ OWN WORDS, they relate the importance of their work:

“Gaps in medical education—including limited exposure to evidence-based approaches to patient engagement using motivational interviewing and harm reduction principles—leave some medical providers without clear guidance on how to effectively work with this vulnerable population.”

“Here we address several common clinical challenges encountered by medical providers on inpatient psychiatric services caring for patients with substance-related and addictive disorders. Though our observations certainly will apply to other clinical services (eg, inpatient general medicine and ambulatory psychiatry), we have developed this commentary with a focus on the inpatient addiction care setting both because it is where we have made these observations most frequently, and because of the intense biopsychosocial instability that we believe demands heightened attention to effective communication from us as providers.”

Filed Under: SAj Blog, Uncategorized

Exciting SAj News!

May 23, 2023 by agalloway

AMERSA is pleased to announce that we have partnered with Sage Publishing as the new publisher of the Substance Abuse journal (SAj.) Sage is a global academic publisher of books, journals, and a growing suite of library products and services. 

The new website for the journal is journals.sagepub.com/home/saj. AMERSA members can access the journal for free via amersa.org/journal-home. All members will receive an email with instructions on how to access our new members portal where member access for the journal is housed. Please contact Adrienne Galloway at adrienne@amersa.org if you have any questions.

Journal Title Change! The AMERSA Board of Directors and the SAj Editorial Team has long recognized that the title of the journal (Substance Abuse) includes pejorative language which can negatively impact the way society perceives persons with substance use and substance use disorder treatments. Thus, we have secured the name Substance Use & Addiction Journal (SAj) with the goal of formally implementing the change with the first issue of 2024.

The 2022 Annual Conference commentary and the presented abstracts are now available here.

Filed Under: SAj Blog, Uncategorized

Publishing in SAj

Mar 27, 2023 by AMERSA

At long last, we are accepting papers for consideration for publication at SAj at the website https://mc.manuscriptcentral.com/saj. The website describing the journal is not yet active, but if you are in need of the author instructions to submit on this website, please use this page: https://amersa.org/instructions-for-authors-2/. Any questions can be addressed to the editor at SAjEditorAMERSA@gmail.com.

Filed Under: SAj Blog Tagged With: manuscripts, publishing, submissions, submissions to SAj

SAj Accepting Manuscripts for Consideration

Dec 15, 2022 by AMERSA

INSTRUCTIONS TO SUBMIT A PAPER TO SUBSTANCE ABUSE journal (SAJ)

December 14, 2022

SAj (impact factor = 3.9) is entering its 43rd year of publication. In 2022, the Association for Multidisciplinary Education and Research in Substance Use and Addiction (AMERSA) secured a new publisher for the journal (SAGE Publications, Inc). All of the notoriety, journal metrics, editorial effectiveness, and activities of the journal will successfully transfer to the new publisher. 

While the new website portal to submit to SAj is being developed, we invite you submit your authored work to be considered for publication in SAj to us directly via email. Submission will be peer reviewed (blinded to reviewers and authors) and its outcome for publication in SAj will be adjudicated relatively quickly by the editorial team. Accepted articles through this email process will be published in SAj in the print journal in 2023. Once published, we will highly promote your findings, commentary, and/or narrative through our blog and social media platforms.

In order to submit to SAj during the publisher transition, please follow the following instructions:

  1. Please FORMAT your manuscript as described at https://amersa.org/instructions-for-authors-2/ . Please note that these instructions are dynamic and may change during the transition to a new publisher, but the types, general format, and word counts/limits will be maintained. 
  2. Please submit your COMPLETE MANUSCRIPT (including cover page, abstract, references, tables, figures, online appendices, etc.) as an attachment addressed to the email below.  This document represents your entire work. Please title the COMPLETE MANUSCRIPT title with the word COMPLETE, corresponding author’s last name, year of submission, month of submission date of submission (e.g., COMPLETE_GORDON_2022_12_14). Please submit as a Microsoft Word document.
  3. Please submit your BLINDED MANUCRIPT (no cover page, no identifying information throughout the narrative/text using blacked out text “…University of Utah IRB…”)) as an attachment addressed to the email below. Please label the BLINDED article with a brief descriptive name, year of submission (YYYY), date of submission (MMDD) (e.g., BLINDED_PerspectivesOfOpioidPrescribers_2022_12_14). This document will be converted to a .pdf file (by us) and sent to external peer reviewers. Please submit the BLINDED MANUSCRIPT as a Microsoft Word document.
  4. Please submit a COVER LETTER which confirms, attests, and relates the following. Please title the COVER LETTER title with the word COVER, corresponding author’s last name, year of submission, month of submission date of submission (e.g., COVER_GORDON_2022_12_14). Please submit the COVER LETTER as a .pdf formatted document.
    1. Confirm that the paper represents original work and that its content has not been published elsewhere and is not under consideration for publication elsewhere
    1. Confirm that all the authors have approved the final version of the manuscript
    1. Provide an accounting whether the work has been presented in oral or poster form and, if so, what conference/venue was the work presented at and the date(s) of the presentation
    1. Declare any conflict of interests of any of the authors
    1. Attest and provide permission for any second party material has been obtained and will be submitted as evidence
  5. If your work has been previously peer-reviewed in other journals and you have revised your work based on these prior reviews, we welcome you to provide 1) the prior reviews and 2) your responses to the prior reviews in the COVER LETTER. We expect that you will provide these prior reviews in total, without editing or elimination of narrative you deem not appropriate. Please see our author instruction website for further instructions on this process. This may, but is not guaranteed, to expedite our review process.
  6. Upon receipt of your email with 3 attachments a “received SAj submission” email will be sent within 24 hours.

All submissions should be sent to Adam J. Gordon MD MPH, SAj Editor-In-Chief at the email address: SAjEditorAMERSA@gmail.com. Questions about this process can also be addressed at that email.

Filed Under: SAj Blog Tagged With: manuscripts, submissions

SAj Flashback: Inhalant Use and Risky Behavior Correlates in a Sample of Rural Middle School Students

Oct 14, 2022 by AMERSA

In this SAj Flashback, we take it all the way back to 2008 with “Inhalant Use and Risky Behavior Correlates in a Sample of Rural Middle School Students” from authors Jessica Legge Muilenburg, PhD and William D. Johnson, PhD.

At the time, this study found 20.4% of children attending a middle school located in rural Mississippi had used inhalants to “get high,” a figure that is much larger than the national average. Many (3.4%) students reported they had used inhalants on 10 or more occasions. Inhalant use was most associated with being younger, ever smoking, riding with a driver who had been drinking, and being involved in a fight. Nearly twice as many younger students reported usage in our sample compared to other studies. Longitudinal studies need to be conducted to investigate whether use of inhalants is a precursor to other risky behaviors, and subsequent progression to alcohol abuse or illicit drug use.

You can still read this article in SAj Volume 27, Issue 4 or online.

Follow us on twitter to stay up to date with SAj!

Filed Under: SAj Blog Tagged With: flashback, SUD

  • « Previous Page
  • 1
  • …
  • 12
  • 13
  • 14
  • 15
  • 16
  • …
  • 88
  • Next Page »

Copyright © 2025
Site by: web360